Pfizer (PFIZER.NS) Azione Prezzo
Pfizer Prezzo
Il fatturato è cresciuto a un tasso composto del 6,7% annuo negli ultimi 20 anni, raggiungendo 22,81 miliardi INR. L'utile per azione è cresciuto del 10,5% all'anno negli ultimi 20 anni. Il margine netto di Pfizer si attesta al 33,6%, in aumento rispetto al 22,2% di alcuni anni fa. Pfizer offre attualmente un rendimento da dividendo di circa il 3,41%. Il payout ratio è pari a circa il 77% degli utili. Il dividendo è cresciuto del 13,7% all'anno negli ultimi 20 anni. Gli analisti fissano un target di prezzo mediano di 6222,00 INR, ovvero il 63,4% sopra il prezzo attuale. Su 8 analisti, 5 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Pfizer Prezzo delle azioni
Pfizer Azione e analisi azionaria
Domande frequenti sull'azione Pfizer
The business model of Pfizer Ltd revolves around pharmaceutical research, development, manufacturing, and sales. As a leading global biopharmaceutical company, Pfizer focuses on discovering breakthrough medicines and vaccines for various health conditions. With a diverse portfolio, Pfizer aims to improve patient lives and promote better health outcomes by investing in innovative research and development. Through strategic partnerships and collaborations, Pfizer strives to advance healthcare solutions while maintaining a strong commitment to delivering quality products. By upholding high standards of scientific integrity and ethical business practices, Pfizer continues to contribute to the well-being of individuals worldwide.
Pfizer Ltd is primarily active in the pharmaceutical industry. Its core business focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. Pfizer Ltd is a renowned global pharmaceutical company, known for its breakthrough medicines and innovative therapies across various therapeutic areas. With a strong presence in the healthcare sector, Pfizer Ltd strives to enhance and improve the well-being of individuals worldwide.
The main competitors of Pfizer Ltd in the market include pharmaceutical companies such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, and Novartis.
Pfizer Ltd. is a renowned pharmaceutical company with a rich history and background. Founded in 1849, Pfizer has evolved into a leading global player in the healthcare industry. With headquarters in the United States, the company has expanded its reach worldwide, including operations in India through Pfizer Ltd. Pfizer Ltd. is committed to discovering, developing, and manufacturing innovative medicines, vaccines, and consumer healthcare products. The company's relentless pursuit of medical advancements and dedication to improving people's lives has earned Pfizer Ltd. a strong reputation and recognition as a trusted name in the pharmaceutical sector.
Pfizer Ltd, a renowned pharmaceutical company, has achieved several significant milestones over the years. Notably, Pfizer is credited with the development of life-saving drugs like Viagra, Lipitor, and Zoloft, which have had a tremendous impact on global healthcare. Pfizer's contributions in the fields of immunology, oncology, and cardiology have not gone unnoticed, establishing the company as a leader in medical advancements. Pfizer's commitment to research and innovation has resulted in groundbreaking treatments, ensuring better clinical outcomes for patients worldwide. This dedication to excellence and their bold pursuit of scientific breakthroughs have made Pfizer Ltd a trusted and influential player in the pharmaceutical industry.
Pfizer Ltd, a leading pharmaceutical company, has a prominent presence in various countries and regions globally. The company operates in several key markets, including the United States, Europe, Asia-Pacific, Latin America, and Africa. With its headquarters in New York, Pfizer Ltd has established a strong foothold in the United States, utilizing its extensive network for research, development, and distribution of innovative healthcare solutions. Additionally, Pfizer Ltd's operations span across Europe, where it operates in numerous countries, catering to diverse healthcare needs. Further, the company's presence extends to the Asia-Pacific region, Latin America, and Africa, emphasizing its commitment to addressing global health challenges effectively.
Pfizer Ltd represents a set of core values and a strong corporate philosophy. As a renowned pharmaceutical company, Pfizer Ltd is committed to innovation and scientific advancement in the healthcare industry. The company believes in providing high-quality and safe medications to improve patient outcomes. Pfizer Ltd also emphasizes integrity, ethical practices, and transparency in all aspects of its operations. With a dedication to research and development, Pfizer Ltd aims to discover and deliver life-saving and life-enhancing therapies for people worldwide. This commitment, along with a customer-centric approach, makes Pfizer Ltd a trusted name in the pharmaceutical sector.
Gli analisti fissano attualmente un prezzo obiettivo medio di 6389,08 INR per l’azione Pfizer (mediana: 6222,00 INR), pari a +67,8 % rispetto all’ultimo prezzo. Il consenso si basa su 8 giudizi di analisti.
9 analisti valutano attualmente l’azione Pfizer: 6 raccomandano l’acquisto, 3 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Pfizer ricavi pari a 25,29 miliardi INR e un utile per azione di 163,25 INR.
Convertita al tasso di cambio attuale, l’azione Pfizer quota 35,15 EUR (3808,20 INR).
L’azione Pfizer (PFIZER.NS) è quotata su 2 borse, tra cui: NSE (Indien) (PFIZER.NS).
Pfizer Ltd is a pharmaceutical company that focuses on the research, development, and marketing of products for the prevention and treatment of diseases. It has a global customer base and operates in various medical fields such as oncology, immunology, neurology, and infectious diseases. The company offers a wide range of medications, from well-established drugs to new therapies and biotechnological products. Its business model is centered on growth and profitability, with investments in research and development to remain competitive. Pfizer Ltd is organized into different divisions, including oncology, infectious diseases, immunology, and neurology, and also engages in the development of biotechnology products. Its products are marketed globally through pharmaceutical distribution channels. Overall, Pfizer Ltd strives to improve the health of patients worldwide through the development and marketing of innovative therapies.
Il attesa fatturato di Pfizer ammonta a 25,29 miliardi INR. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Pfizer ammonta a 7,47 miliardi INR. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Pfizer è attualmente 23,33. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Pfizer.
Il rapporto prezzo/fatturato (P/S) di Pfizer è attualmente 6,89. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Pfizer.
Il Quality Score AlleAktien per Pfizer è 5/10.
L'ISIN di Pfizer è INE182A01018. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di Pfizer è PFIZER.NS. Con questo simbolo di borsa vengono negoziate le azioni Pfizer in borsa.
Azione Pfizer
Gruppo di pari di Pfizer
Pfizer Ticker
Pfizer FIGI
Altre metriche e analisi di Pfizer in Deep Dive.
La nostra analisi azionaria dell'azione Pfizer include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Pfizer. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: